FDA grants Fast Track and Orphan Drug Designation to Aprea Therapeutics’ APR-246 Drug for the Treatment of MDS

The U.S. Food and Drug Administration has granted a Fast Track designation to Aprea Therapeutics’ APR-246...
Read more of this post

Growth in Prescription Drug Abuse will boost the Demand for Rapid Oral Fluid Screening Devices

Rapid oral fluid screening devices are test kits that are used for drugs of abuse testing....
Read more of this post

Increasing healthcare expenditure will leverage the demand for additional supplements products

The global market for Citicoline was valued at US$ 495.1 Mn in 2017. The market is...
Read more of this post

Controlled Substances Market Analysis, Trends, Forecast, 2018-2028

Worldwide sales of the controlled substances closed in on a valuation of US$ 67,000 Mn in...
Read more of this post